Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.495EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.354EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.581EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.330EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.590EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.496EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.49 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.497EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.30 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.85 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used